Keyword: InFLAMES Flagship

Senior Researcher Pekka Postila from the University of Turku and InFLAMES Flagship has been awarded  €120,000 Investigator Award from the California-based SynGAP Research Fund to investigate the effects of missense mutations on the SynGAP1 protein. Additionally, Doctoral Researcher Aliaa E. Ali has received full two-year PhD funding from the Finnish Cultural Foundation for her work on SynGAP1 modeling.

A multicentre study led from Finland has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to improve the outcomes of the transfer treatment continues to be sought. 

In the context of the 34th BioCity Symposium “Transforming Drug Development for Tomorrow” (28-29 August 2025) the twenty-first Elias Tillandz prize will be awarded for the best scientific paper published in 2024 in Turku.

Finnish researchers show in a new study that pituitary macrophages, the immune cells located in the pituitary gland, help regulate hormonal balance. It is possible that in the future, macrophage cells could be used to treat endocrine disorders that can lead, for example, to infertility.

Professor Cecilia Söderberg-Nauclér, InFLAMES group leader from the University of Turku, is investigating the links between human cytomegalovirus and brain tumours in a multi-million euro research project conducted in collaboration between researchers in Finland, Denmark, and Sweden. The Lundbeck Foundation has awarded a grant of approximately €4 million for the project.

How can sensitive health data be used responsibly in scientific research or how can artificial intelligence help make breakthroughs in medical research? The ECCB2024 conference brings together current themes in computational biology and international researchers in Turku, Finland.